SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC

NCT06457906 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer
Brain Metastases
SRS
Stereotactic Radiotherapy
Whole Brain Radiotherpay
Hippocampal-avoidance

Interventions

COMBINATION_PRODUCT: Experimental group (SRS/SRT/Hypo-RT)
RADIATION: Controled group (HA-WBRT)

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences